Cargando…
Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma
We studied longitudinally inflammatory reactions and serum C-reactive protein (S-CRP) levels in 52 colorectal cancer patients treated with a median of six 3-weekly cycles of raltitrexed 1.5–3.0 mg m(−2) combined with oral carmofur (1-hexylcarbomoyl-5-fluorouracil) 300–400 mg m(−2) on cycle days 2–14...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2002
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364241/ https://www.ncbi.nlm.nih.gov/pubmed/12237767 http://dx.doi.org/10.1038/sj.bjc.6600520 |